Abstract
In a randomized, double-blind study, we compared the prophylactic efficacy of ondansetron at a dose of 0.1 mg/kg (OND) vs. droperidol at a dose of 0.075 mg/kg (DBP) vs. placebo (PLA) in 120 patients undergoing pediatric 1-day ophthalmic surgery. Results showed an incidence of emesis in 10% of the OND group, in 37.5% of the DBP group and in 65% of the PLA group. Prophylactic administration of ondansetron represents the anti-emetic agent of choice in pediatric 1-day ophthalmic surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
